WithdrawnNCT03895658
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
Device studyAges 22–70United StatesDepression
Understand this study
Who could participate?
Listed age limits: 22 years to 70 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 26, 2025
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Device
- Intervention type
- Device
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 22 Years to 70 Years
- Official registry ID
- NCT03895658
- Official title
Show the full official title
Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Who can participate?
Listed age limits: 22 years to 70 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
